Lyra Therapeutics (LYRA) delivered earnings and revenue surprises of 21.74% and 51.25%, respectively, for the quarter ended September 2024. Do the...
Vous n'êtes pas connecté
Zevra Therapeutics (ZVRA) delivered earnings and revenue surprises of -56.82% and 26.69%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Lyra Therapeutics (LYRA) delivered earnings and revenue surprises of 21.74% and 51.25%, respectively, for the quarter ended September 2024. Do the...
BioXcel Therapeutics (BTAI) delivered earnings and revenue surprises of 36% and 82.17%, respectively, for the quarter ended September 2024. Do the...
Tango Therapeutics (TNGX) delivered earnings and revenue surprises of 20.59% and 44.35%, respectively, for the quarter ended September 2024. Do the...
Voyager Therapeutics (VYGR) delivered earnings and revenue surprises of 64.44% and 95%, respectively, for the quarter ended September 2024. Do the...
Fate Therapeutics (FATE) delivered earnings and revenue surprises of 4.76% and 249.32%, respectively, for the quarter ended September 2024. Do the...
Conduent (CNDT) delivered earnings and revenue surprises of 12.50% and 1.10%, respectively, for the quarter ended September 2024. Do the numbers hold...
Exact Sciences (EXAS) delivered earnings and revenue surprises of -5% and 1.22%, respectively, for the quarter ended September 2024. Do the numbers...
Arteris (AIP) delivered earnings and revenue surprises of 42.86% and 0.25%, respectively, for the quarter ended September 2024. Do the numbers hold...
BigBear.ai (BBAI) delivered earnings and revenue surprises of 28.57% and 8.42%, respectively, for the quarter ended September 2024. Do the numbers...
Zevia (ZVIA) delivered earnings and revenue surprises of 63.64% and 5.60%, respectively, for the quarter ended September 2024. Do the numbers hold...